Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
暂无分享,去创建一个
Donna Richardson | Adrian L Harris | A. Harris | K. O'Byrne | C. Wykoff | J. Pastorek | H. Turley | J. Jones | D. Richardson | Helen Turley | Jaromir Pastorek | Daniel E B Swinson | J Louise Jones | Kenneth J O'Byrne | Charles Wykoff | Nick Taub | D. Swinson | N. Taub | J. Jones
[1] L. H. Gray,et al. The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.
[2] J. Folkman,et al. Vascular injury in transplanted tissues. Fine structural changes in tumor, adult, and embryonic blood vessels. , 1976, Virchows Archiv. B, Cell pathology.
[3] H. Dienemann,et al. Importance of microscopic residual disease at the bronchial margin after resection for non-small-cell carcinoma of the lung. , 1992, The Journal of thoracic and cardiovascular surgery.
[4] S. Pastoreková,et al. A novel quasi-viral agent, MaTu, is a two-component system. , 1992, Virology.
[5] B. Teicher,et al. A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. , 1993, Anticancer Research.
[6] J. Pastorek,et al. Expression of MaTu‐MN protein in human tumor cultures and in clinical specimens , 1993, International journal of cancer.
[7] W. Kao,et al. Expression of collagen I, smooth muscle alpha-actin, and vimentin during the healing of alkali-burned and lacerated corneas. , 1993, Investigative ophthalmology & visual science.
[8] J. Minna,et al. Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. , 1994, Oncogene.
[9] P Vaupel,et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.
[10] E. Stanbridge,et al. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. , 1997, Cancer research.
[11] H. Hoffmann,et al. Inkomplette Resektionen bei Bronchialcarcinom: Morbidität und Prognose , 1997, Der Chirurg.
[12] J. Pastorek,et al. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. , 1998, The American journal of pathology.
[13] A S Kennedy,et al. Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. , 1998, Gynecologic oncology.
[14] G. Arteel,et al. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. , 1999, Radiation research.
[15] L. Voltolini,et al. Treatment and survival after lung resection for non-small cell lung cancer in patients with microscopic residual disease at the bronchial stump. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[16] A. Burny,et al. Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma. , 1999, The European respiratory journal.
[17] M Molls,et al. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. , 1999, International journal of radiation oncology, biology, physics.
[18] P H Watson,et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. , 2000, Cancer research.
[19] Abdul Waheed,et al. Nuclear NonO/p54nrb Protein Is a Nonclassical Carbonic Anhydrase* , 2000, The Journal of Biological Chemistry.
[20] E. Stanbridge,et al. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia , 2000, Cancer.
[21] G. Semenza,et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. , 2000, Cancer research.
[22] S. Leroy,et al. Temporal trends in survival after surgical resection of localized non-small cell lung cancer. , 2000, Lung cancer.
[23] K. Haustermans,et al. Diffusion limited hypoxia estimated by vascular image analysis: comparison with pimonidazole staining in human tumors. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[24] R K Jain,et al. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha--> hypoxia response element--> VEGF cascade differentially regulates vascular response and growth rate in tumors. , 2000, Cancer research.
[25] K. O'Byrne,et al. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer , 2000, British Journal of Cancer.
[26] W. Sly,et al. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[27] C. Supuran,et al. Carbonic anhydrase inhibitors: sulfonamides as antitumor agents? , 2001, Bioorganic & medicinal chemistry.
[28] K. O'Byrne,et al. A biological staging model for operable non-small cell lung cancer , 2001, Thorax.
[29] A. Harris,et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. , 2001, Cancer research.
[30] A. Harris,et al. Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival , 2001, British Journal of Cancer.
[31] A. Harris,et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] A. Harris,et al. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. , 2001, Cancer research.
[33] K. Yoshikawa,et al. [The role of MN/CA IX antigen in carcinogenesis and metastasis of renal cell carcinoma]. , 2001, Hinyokika kiyo. Acta urologica Japonica.
[34] N Zamboglou,et al. Predictive factors in radiotherapy for non-small cell lung cancer: present status. , 2001, Lung cancer.
[35] A. Harris,et al. Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway , 2001, British Journal of Cancer.
[36] W. Sly,et al. Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. , 2001, The American journal of pathology.
[37] R. Silber,et al. Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[38] Donna Richardson,et al. Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables. , 2002, Lung cancer.